Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06135324 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Impairments That Affect Correct Inhaler Use in COPD

Study acronym: INHALE
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Recruiting to Active, Not Recruiting
    • Study sites: 10 to 9
    • Primary completion date changed from estimate of Dec 2024 to Apr 30, 2025
    • Study completion date: Jul 19, 2025 to Oct 31, 2025
    v7
  2. Site details revised at 10 of 10 sitesv6
  3. Study sites: 8 to 10v5
  4. Study sites: 4 to 8
    • Primary completion date: Jul 2024 to Dec 2024
    v4
  5. Study sites: 1 to 4v3
  6. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Dec 2023 to Dec 14, 2023
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
COPD Foundation
4 trials monitored
See all monitored trials
COPD
1,119 trials monitored
See 34 trials at risk
INHALE is a one-year, multi-site observational research study funded by Viatris, with two aims: 1. Determine the prevalence of both cognitive impairment and impaired manual dexterity in stable out-patients with chronic obstructive pulmonary disease (COPD). 2. Assess the relationship of cognitive impairment and impaired manual dexterity with patient errors using current pMDIs, SMIs and/or DPIs.
Trial Details
NCT Number NCT06135324
Lead Sponsor COPD Foundation
Collaborators: Viatris Inc.
Conditions
(from sponsor)		 COPD
Related terms Pulmonary Disease, Chronic Obstructive
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov